We serve Chemical Name:2,6-Dichloroisonicotinaldehyde CAS:113293-70-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2,6-Dichloroisonicotinaldehyde
CAS.NO:113293-70-2
Synonyms:4-Pyridinecarboxaldehyde, 2,6-dichloro-;2,6-dichloropyridine-4-carbaldehyde;MFCD00124816;2,6-Dichloroisonicotinaldehyde
Molecular Formula:C6H3Cl2NO
Molecular Weight:176.000
HS Code:2933399090
Physical and Chemical Properties:
Melting point:47-48°C
Boiling point:276.7±35.0 °C at 760 mmHg
Density:1.5±0.1 g/cm3
Index of Refraction:1.608
PSA:29.96000
Exact Mass:174.959167
LogP:1.83
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:
Contact us for information like 4-Pyridinecarboxaldehyde, 2,6-dichloro- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2,6-Dichloroisonicotinaldehyde physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD00124816 Use and application,4-Pyridinecarboxaldehyde, 2,6-dichloro- technical grade,usp/ep/jp grade.
Related News: Government prosecutors often consider whether a corporation made a genuine effort to investigate and address potentially illegal activities once learning of them. 2,6-Dichloroisonicotinaldehyde manufacturer With the speeding up of review and approval, the number of approved innovative drugs in China is about to usher in a year of blowout. 2,6-Dichloroisonicotinaldehyde supplier Roche’s second anti-tau antibody UCB0107, partnered with UCB, is also slated to enter deeper testing this year. Tau had appeared to have fresh promise as a rival of sorts to amyloid. Tau theory goes that neurofibrillary tangles that form inside cells clog up the brain, and clearing this can help Alzheimer’s patients. 2,6-Dichloroisonicotinaldehyde vendor In recent years, with the increasing number of patent medicines whose patents have expired, the variety and quantity of generic drugs have also increased rapidly, which has brought huge market opportunities to the API market and the output of APIs has continued to increase. 2,6-Dichloroisonicotinaldehyde factory In recent years, with the increasing number of patent medicines whose patents have expired, the variety and quantity of generic drugs have also increased rapidly, which has brought huge market opportunities to the API market and the output of APIs has continued to increase.
